Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults

ClinicalTrials.gov ID: NCT00043927

Public ClinicalTrials.gov record NCT00043927. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 4:01 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Multicenter, Randomized, Phase III Study Comparing Oral Topotecan/Cisplatin Versus Etoposide/Cisplatin as Treatment for Chemotherapy-naive Patients With Extensive Disease-Small Cell Lung Cancer.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will gather and compare data about the effectiveness and safety of two different treatments for extensive Small Cell Lung Cancer (SCLC) in patients who have not received previous chemotherapy. One treatment will use an investigational drug in combination with an FDA approved chemotherapy. The other treatment will use a combination of two FDA approved chemotherapy drugs.

Study identification

NCT ID
NCT00043927
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
760 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2001 (Type not available)
Primary completion
Jan 2004 (Actual)
Completion
Not listed
Last update posted
Aug 21, 2013

Started 2001

United States locations

U.S. sites
66
U.S. states
30
U.S. cities
60
Facility City State ZIP Site status
GSK Clinical Trials Call Center Hoover Alabama 35216 —
GSK Clinical Trials Call Center Chula Vista California 91911 —
GSK Clinical Trials Call Center Fountain Valley California 92708 —
GSK Clinical Trials Call Center Greenbrae California 94904 —
GSK Clinical Trials Call Center Poway California 92064 —
GSK Clinical Trials Call Center Rancho Mirage California 92270 —
GSK Clinical Trials Call Center Sacramento California 95816-5616 —
GSK Clinical Trials Call Center San Diego California 92102-8421 —
GSK Clinical Trials Call Center San Diego California 92121 —
GSK Clinical Trials Call Center Soquel California 95073 —
GSK Clinical Trials Call Center Vista California 92083 —
GSK Clinical Trials Call Center Colorado Springs Colorado 80909 —
GSK Clinical Trials Call Center Norwich Connecticut 06360 —
GSK Clinical Trials Call Center Washington D.C. District of Columbia 20307-5001 —
GSK Clinical Trials Call Center Gainesville Florida 32610 —
GSK Clinical Trials Call Center Miami Shores Florida 33138 —
GSK Clinical Trials Call Center Ocala Florida 34471 —
GSK Clinical Trials Call Center Pensacola Florida 32501 —
GSK Clinical Trials Call Center Tarpon Springs Florida 34689 —
GSK Clinical Trials Call Center Atlanta Georgia 30030 —
GSK Clinical Trials Call Center Atlanta Georgia 30308 —
GSK Clinical Trials Call Center Atlanta Georgia 30328 —
GSK Clinical Trials Call Center Atlanta Georgia 30335 —
GSK Clinical Trials Call Center Augusta Georgia 30912 —
GSK Clinical Trials Call Center Cumming Georgia 30040 —
GSK Clinical Trials Call Center Decatur Georgia 30033 —
GSK Clinical Trials Call Center Aurora Illinois 60506 —
GSK Clinical Trials Call Center Chicago Illinois 60612 —
GSK Clinical Trials Call Center Chicago Illinois 60637-1470 —
GSK Clinical Trials Call Center Elk Grove Village Illinois 60007 —
GSK Clinical Trials Call Center Park Ridge Illinois 60068 —
GSK Clinical Trials Call Center Evansville Indiana 47713 —
GSK Clinical Trials Call Center South Bend Indiana 46601 —
GSK Clinical Trials Call Center New Orleans Louisiana 70112 —
GSK Clinical Trials Call Center Shreveport Louisiana 71103 —
GSK Clinical Trials Call Center Frederick Maryland 21701 —
GSK Clinical Trials Call Center Pittsfield Massachusetts 01201 —
GSK Clinical Trials Call Center Minneapolis Minnesota 55404 —
GSK Clinical Trials Call Center St Louis Missouri 63141 —
GSK Clinical Trials Call Center Reno Nevada 89502 —
GSK Clinical Trials Call Center Voorhees Township New Jersey 08043 —
GSK Clinical Trials Call Center Albuquerque New Mexico 87109 —
GSK Clinical Trials Call Center Albany New York 12208 —
GSK Clinical Trials Call Center New York New York 10021 —
GSK Clinical Trials Call Center New York New York 10032 —
GSK Clinical Trials Call Center Rochester New York 14623 —
GSK Clinical Trials Call Center Valhalla New York 10595 —
GSK Clinical Trials Call Center Bismarck North Dakota 58501 —
GSK Clinical Trials Call Center Cleveland Ohio 44106-5065 —
GSK Clinical Trials Call Center Columbus Ohio 43222 —
GSK Clinical Trials Call Center Portland Oregon 97232-2099 —
GSK Clinical Trials Call Center Lemoyne Pennsylvania 17043 —
GSK Clinical Trials Call Center Limerick Pennsylvania 19468 —
GSK Clinical Trials Call Center Philadelphia Pennsylvania 19140 —
GSK Clinical Trials Call Center Columbia South Carolina 29203 —
GSK Clinical Trials Call Center Spartanburg South Carolina 29303 —
GSK Clinical Trials Call Center Memphis Tennessee 38119 —
GSK Clinical Trials Call Center Fort Worth Texas 76104 —
GSK Clinical Trials Call Center Houston Texas 77060 —
GSK Clinical Trials Call Center Abingdon Virginia 24211 —
GSK Clinical Trials Call Center Norfolk Virginia 23502 —
GSK Clinical Trials Call Center Olympia Washington 98506 —
GSK Clinical Trials Call Center Yakima Washington 98902 —
GSK Clinical Trials Call Center Morgantown West Virginia 26506 —
GSK Clinical Trials Call Center Madison Wisconsin 53792 —
GSK Clinical Trials Call Center Laramie Wyoming 82070 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 110 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00043927, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 21, 2013 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00043927 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →